Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The fair value estimate for Laurus Labs has been reset from ₹863.13 to ₹913.47, ...
Motilal Oswal remains positive on Laurus Labs stock due to its strengthening position in gaining CDMO contracts, the addition ...
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research ...
The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...
Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...
Hosted on MSN
Laurus Labs share price surges over 18% in June, outperforms Sensex. What's next for this pharma stock?
Laurus Labs share price rose over 2% during Monday's trading session to touch an 52-week high of ₹720.90 apiece on the BSE, marking the stock's third consecutive day of gains in a bullish trend. So ...
Earnings call Laurus Labs delivered Q3 FY26 revenue of ₹1,778 crore (up 26% YoY), EBITDA margin expanded to 27%, and PAT surged 388% YoY to ₹252 crore. CDMO grew over 50% YTD, generics rose 37% YoY in ...
BENGALURU, Jan 30 (Reuters) - India's Laurus Labs Ltd (LAUL.NS), opens new tab reported a 32.1% rise in third-quarter profit on Monday, boosted by strong demand in its businesses that make chemicals ...
SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results